1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Neuronal Properties, In Vivo Effects, and Pathology of a Huntington's Disease Patient-Derived Induced Pluripotent Stem Cells
(
- Contribution to journal › Article
- 2008
-
Mark
Mutant huntingtin can paradoxically protect neurons from death
(
- Contribution to journal › Scientific review
- 2007
-
Mark
Decreased VIP and VPAC(2) receptor expression in the biological clock of the R6/2 Huntington's disease mouse
(
- Contribution to journal › Article
- 2005
-
Mark
Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction.
(
- Contribution to journal › Article
-
Mark
Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice.
(
- Contribution to journal › Article
-
Mark
Synaptic dysfunction in Huntington's disease: a new perspective
(
- Contribution to journal › Scientific review
- 2004
-
Mark
Harnessing endogenous stem cells to treat neurodegenerative disorders of the basal ganglia.
(
- Contribution to journal › Article
- 2002
-
Mark
Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice.
(
- Contribution to journal › Article
- 2001
-
Mark
Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine
(
- Contribution to journal › Article
-
Mark
Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene
(
- Contribution to journal › Article